Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09IXX
|
||||
| Former ID |
DIB017010
|
||||
| Drug Name |
Delta-9-tetrahydrocannabinol prodrugs
|
||||
| Synonyms |
Cannabinoid-2 modulator (gel, pain/osteoarthritis), Alltranz; Cannabinoid prodrugs (transdermal patch/gel, pain/osteoarthritis/cannabis dependence), AllTranz; Delta-9-tetrahydrocannabinol prodrugs (transdermal patch/gel, pain/osteoarthritis/cannabis dependence); Delta-9-tetrahydrocannabinol prodrugs (transdermal patch/gel, pain/osteoarthritis/cannabis dependence), AllTranz
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Investigative | [543878] | ||
| Company |
AllTranz Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 2 | Target Info | Modulator | [543878] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.